Skip to main content
Clinical Trials/NCT05651399
NCT05651399
Completed
Phase 4

Comparison in Frequency of Hypotension During Sedation of Propofol and Remimazolam in Spinal Anesthesia in Hip Surgery Patients: a Randomized Controlled Clinical Trial

Asan Medical Center1 site in 1 country78 target enrollmentDecember 26, 2022

Overview

Phase
Phase 4
Intervention
Remimazolam
Conditions
Remimazolam
Sponsor
Asan Medical Center
Enrollment
78
Locations
1
Primary Endpoint
Frequency of hypotension during surgery (1hour)
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to compare the incidence of hypotension between remimazolam and propofol for intraoperative sedation in patients undergoing hip surgery with spinal anesthesia.

Registry
clinicaltrials.gov
Start Date
December 26, 2022
End Date
June 14, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hajung Kim

Clinical assistant professor

Asan Medical Center

Eligibility Criteria

Inclusion Criteria

  • ASA physical status 1-3
  • Patients scheduled for hip joint surgery under spinal anesthesia and sedation with propofol or remimzolam

Exclusion Criteria

  • Patients who refuse to participate in this study
  • Patients with uncontrolled high blood pressure, hyperthyroidism, dementia in the inability to communicate, or symptomatic coronary artery disease
  • Patients with an allergy to propofol, fentanyl, or bupivacaine
  • Patients contraindicated for spinal anesthesia, such as coagulopathy, severe aortic stenosis/mitral stenosis, and active infection on lumbar region
  • Patients judged to be inappropriate for this study

Arms & Interventions

Remimazolam

A maintenance dose of remimazolam is administered for sedation

Intervention: Remimazolam

Propofol

A maintenance dose of propofol is administered for sedation

Intervention: Propofol

Outcomes

Primary Outcomes

Frequency of hypotension during surgery (1hour)

Time Frame: up to 1 hour after initiation of drug infusion

mean blood pressure less than 65mmHg

Secondary Outcomes

  • Frequency of hypotension during surgery(Throughout the surgery)
  • Total administered phenylephrine(Throughout the surgery)
  • Fluid volume(Throughout the surgery)
  • Number of hypotensive episodes in the post-anesthesia care unit after surgery(up to 1 hour after postanesthesia care unit entry)
  • Complications after surgery(up to 7 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials